Sign in / Join Now
ETFs & Funds
Nice! Long $
Strategic plans moving along. Much greater upside than down from here. Stay long.
It cannot get any better than this with this collection of luminaries in medicine. This is a stock of the future.
seriously it will be keeping company with regeneron someday.
Add a reply...
Latest StockTalks »
people get PMCB breaking news and analysis by email alert.
Get email alerts on PMCB »
PharmaCyte Biotech, Inc.
Get latest price
From other sites
PharmaCyte Biotech Discusses Upcoming Clinical Trial In Pancreatic Cancer With First Principal Investigator
at TheStreet (Wed, 9:00AM)
PharmaCyte Biotech Granted FDA Pre-IND Meeting For Pancreatic Cancer Therapy
at TheStreet (Nov 29, 2016)
University Of Northern Colorado Presenting PharmaCyte Biotech's Cannabis Research At The 2017 American Chemical Society National Meeting
at TheStreet (Nov 14, 2016)
PharmaCyte Biotech Requests Pre-IND Meeting With FDA For Its Pancreatic Cancer Clinical Trial
at TheStreet (Nov 1, 2016)
PharmaCyte Biotech Selects Dr. Manuel Hidalgo As Principal Investigator For Its Pancreatic Cancer Clinical Trial
at TheStreet (Oct 24, 2016)